Jessica K Altman Selected Research

Jessica K Altman Research Topics

Disease

48	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 05/2007
19	Leukemia 09/2023 - 01/2008
16	Neoplasms (Cancer) 12/2023 - 05/2007
10	Acute Promyelocytic Leukemia 01/2021 - 05/2007
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 05/2015
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2023 - 07/2010
6	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 03/2008
2	Blast Crisis (Blast Phase) 01/2024 - 11/2014
2	Hairy Cell Leukemia 12/2022 - 10/2015
2	Pneumonia (Pneumonitis) 12/2022 - 01/2021
2	Exanthema (Rash) 12/2022 - 10/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2013
2	Hemorrhage 09/2013 - 06/2007
2	Polycythemia Vera 08/2013 - 12/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2012 - 11/2011
2	Leukocytosis (Pleocytosis) 12/2009 - 01/2008
2	Disseminated Intravascular Coagulation 03/2009 - 06/2007
1	Disease Progression 01/2024
1	Leukopenia 04/2023
1	Febrile Neutropenia 04/2023
1	Thrombocytopenia (Thrombopenia) 04/2023
1	Fever (Fevers) 12/2022
1	COVID-19 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Pancytopenia 01/2022
1	Abnormal Karyotype 01/2022
1	Anemia 01/2021
1	Left Ventricular Dysfunction 11/2019
1	Fibrosis (Cirrhosis) 08/2019
1	Splenomegaly 08/2019
1	Primary Myelofibrosis (Myelosclerosis) 08/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2019
1	Histiocytic Sarcoma 03/2019

Drug/Important Bio-Agent (IBA)

10	Phosphotransferases (Kinase)IBA 05/2021 - 01/2008
8	Arsenic Trioxide (Trisenox)FDA Link 01/2015 - 01/2008
5	gilteritinibIBA 12/2022 - 10/2020
5	AnthracyclinesIBA 11/2019 - 01/2008
5	TOR Serine-Threonine KinasesIBA 04/2015 - 01/2008
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2014 - 12/2009
5	Proteins (Proteins, Gene)FDA Link 06/2013 - 06/2007
5	Aligeron (AS 2)IBA 10/2012 - 01/2008
4	Tyrosine Kinase InhibitorsIBA 03/2024 - 11/2013
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 10/2009
4	Mechanistic Target of Rapamycin Complex 2IBA 05/2014 - 07/2010
3	venetoclaxIBA 02/2024 - 01/2021
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 07/2013
3	fms-Like Tyrosine Kinase 3IBA 10/2022 - 01/2018
3	CytokinesIBA 01/2022 - 01/2016
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 10/2010
3	ivosidenibIBA 11/2021 - 01/2020
3	Eukaryotic Initiation Factor-4EIBA 01/2016 - 10/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013 - 05/2007
3	Small Interfering RNA (siRNA)IBA 08/2013 - 05/2010
3	MTOR InhibitorsIBA 06/2013 - 11/2011
2	Tyrosine (L-Tyrosine)FDA Link 09/2023 - 01/2023
2	VemurafenibIBA 12/2022 - 10/2015
2	Hemoglobins (Hemoglobin)IBA 04/2022 - 01/2021
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2020 - 05/2015
2	ruxolitinibIBA 08/2019 - 01/2014
2	enasidenibIBA 01/2019 - 10/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2018 - 10/2017
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2016 - 10/2010
2	Protein Kinases (Protein Kinase)IBA 01/2016 - 09/2012
2	Antineoplastic Agents (Antineoplastics)IBA 04/2015 - 01/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2014 - 07/2011
1	FF-10101IBA 03/2024
1	pembrolizumabIBA 12/2023
1	entinostat (MS 275)IBA 12/2023
1	Histone Deacetylase InhibitorsIBA 12/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2023
1	eprenetapoptIBA 04/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	vorasidenibIBA 01/2023
1	BI 836858IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	midostaurinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	sapacitabineIBA 12/2021
1	tomivosertibIBA 05/2021
1	4-fluorobenzoyl-TN-14003IBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Erythropoietin FDA Link 01/2021
1	Epoetin Alfa (Epogen)FDA Link 01/2021
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2021
1	MLN 8237IBA 08/2019
1	Aurora Kinase AIBA 08/2019
1	isocitric acid (isocitrate)IBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019

Therapy/Procedure

31	Therapeutics 03/2024 - 01/2008
12	Drug Therapy (Chemotherapy) 02/2024 - 01/2008
4	Stem Cell Transplantation 03/2019 - 06/2014
3	Induction Chemotherapy 01/2022 - 11/2019
1	Retreatment 12/2022
1	Radiotherapy 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Precision Medicine 01/2019
1	Consolidation Chemotherapy 01/2018